Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number



Projects 294
Countries 141
Faculty 349
Health Topics 123

Filter from the selections below

Clear All Filters

Mediators of Fatty Liver Disease during HIV/SIV and cART Treatment

In HIV+ patients that are effectively cART treated, liver disease is currently the most common cause of non-AIDS morbidity and mortality. This proposal will address the hypothesis that bacteria and bacterial products (including Mycobacteria) are key mediators of liver inflammation during cART-treated HIV/SIV-infection and can initiate the early events that trigger fatty liver disease. Our long-term goal is to utilize our findings to identify immune therapeutic approaches that prevent/suppress liver disease in HIV+cART treated individuals. 

Active Dates 
02/19/2018 to 01/31/2023
Faculty Involved